Efficacy of low and high i doses for thyroid remnant ablation in patients with differentiated thyroid carcinoma based on post-operative cervical uptake

Nuclear Medicine Communications

Volumn 25, Issue 11, 2004, Pages 1077-1081

  Rosário, Pedro W S ^a   Reis, Janice S ^a   Barroso, Álvaro L ^a   Rezende, Leonardo L ^a   Padrão, Eduardo L ^a   Fagundes, Tales A ^a  

^a Endocrinology Service   (Brazil)

Author keywords

Remnant ablation

Indexed keywords

IODINE 131;

ADULT; AGED; ARTICLE; CANCER SURGERY; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DOSIMETRY; DRUG EFFICACY; FEMALE; HUMAN; IODINE 131 UPTAKE TEST; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; THYROID CARCINOMA; THYROIDECTOMY; TREATMENT OUTCOME;

ADULT; AGED; CARCINOMA; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; HUMANS; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; NECK; NEOPLASM RECURRENCE, LOCAL; POSTOPERATIVE CARE; PROGNOSIS; RADIOPHARMACEUTICALS; RADIOTHERAPY DOSAGE; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; THYROID NEOPLASMS; THYROIDECTOMY; TREATMENT OUTCOME;

EID: 8444220081     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/00006231-200411000-00002     Document Type: Article

References (34)

1. DeGroot LJ, Kaplan EL, McCormick M, Straus FH. Natural history, treatment, and course of papillary thyroid carcinoma. J Clin Endocrinol Metab 1990; 71:414-424.
2. Mazzaferri EL, Kloos RT. Current approaches to primary therapy for papillary and follicular thyroid cancer. J Clin Endocrinol Metab 2001; 96:1447-1463.
3. Schlumberger MJ. Medical progress—papillary and follicular thyroid carcinoma. N Engl J Med 1998; 338:297-306.
4. 131I in the treatment of patients with differentiated thyroid cancer? Nucl Med Commun1996; 17:199-207.
5. Leung SF, Law MW, Ho SK. Efficacy of low-dose iodine-131 ablation of post-operative thyroid remnants: a study of 69 cases. Br J Radiol 1992; 65:905-909.
6. 131iodine based on neck uptake produces effective thyroid ablation and reduced hospital stay. Radiother Oncol 1998; 47:325-330.
7. DeGroot LJ, Reilly M. Comparison of 30 and 50舁mCi doses of iodine-131 for thyroid ablation. Ann Intern Med 1982; 96:51-53.
8. Maxon HR, Englaro EE, Thomas SR, Hertzberg VS, Hinnefeld JD, Chen LS, et al. Radioiodine-131 therapy for well-differentiated thyroid cancer—a quantitative radiation dosimetric approach: outcome and validation in 85 patients. J Nucl Med 1992; 33:1132-1136.
9. 131I dose in differentiated thyroid cancer. Clin Endocrinol 2000; 52:765-773.
10. Gawkowska-Suwinska M, Turska M, Roskosz J, Puch Z, Jurecka-Tuleja B, Handkiewicz-Junak D, et al. Early evaluation of treatment effectiveness using 131 iodine radiotherapy in patients with differentiated thyroid cancer. Wiad Lek 2001; 54:278-288.
11. 131I for remnant ablation in patients with differentiated thyroid carcinoma. Cancer 1996; 77:2574-2580.
12. 131I in patients with differentiated thyroid carcinoma. Nucl Med Commun 2001; 22:1021-1027.
13. Arad E, Flannery K, Wilson GA, O'Mara RE. Fractionated doses of radioiodine for ablation of postsurgical thyroid tissue remnants. Clin Nucl Med 1990; 15:676-677.
14. Wang SJ, Liu TJ. Use of fractionated doses of iodine-131 for ablation of thyroid remnants. Zhonghua Yi Xue Za Zhi (Taipei) 2002; 65:336-340.
15. Roos DE, Smith JG. Randomized trials on radioactive iodine ablation of thyroid remnants for thyroid carcinoma—a critique. Int J Radiat Oncol Bio Phys 1999; 44:493-495.
16. Muratet JP, Daver A, Minier JF, Larra F. Influence of scanning doses of iodine-131 on subsequent first ablative treatment outcome in patients operated on for differentiated thyroid carcinoma. J Nucl Med 1998; 39:1546-1550.
17. Yokoyama N, Nagayama Y, Kakezono F, Kiriyama T, Morita S, Ohtakara S, et al. Determination of the volume of the thyroid gland by a high resolutional ultrasonic scanner. J Nucl Med 1986; 27:1475-1479.
18. Fratkin MJ, Newsome Jr HH, Sharpe Jr AR, Tatum JL. Cervical distribution of iodine-131 following total thyroidectomy for thyroid cancer. Arch Surg 1983; 118:864-867.
19. Logue JP, Tsang RW, Brierley JD, Simpson WJ. Radioiodine ablation of residual tissue in thyroid cancer: relationship between administered activity, neck uptake and outcome. Br J Radiol 1994; 67:1127-1131.
20. Karam M, Gianoukakis A, Feustel PJ, Cheema A, Postal ES, Cooper JA. Influence of diagnostic and therapeutic doses on thyroid remnant ablation rates. Nucl Med Commun 2003; 24:489-495.
21. 131I in patients with differentiated thyroid cancers. Wiad Lek 2001; 54:363-367.
22. Cailleux AF, Baudin E, Travagli JP, Ricard M, Schlumberger M. Is diagnostic iodine-131 scanning useful after total thyroid ablation for differentiated thyroid carcinoma? J Clin Endocrinol Metab 2000; 85:175-178.
23. Attie JN, Moskowitz GW, Margouleff D, Levy LM. Feasibility of total thyroidectomy in the treatment of thyroid carcinoma: postoperative radioactive iodine evaluation of 140 cases. Am J Surg 1979; 138:555-560.
24. Wloch J, Czarniecka A. Early evaluation of results after total thyroidectomy in patients with thyroid cancer. Wiad Lek 2001; 54:210-217.
25. Clark OH. Total thyroidectomy: the treatment of choice for patients with differentiated thyroid cancer. Ann Surg 1982; 196:361-370.
26. Schwartz AE, Friedman EW. Preservation of the parathyroid glands in total thyroidectomy. Surg Gynecol Obstet 1987; 165:327-332.
27. Samuel AM, Rajashekharrao B. Radioiodine therapy for well-differentiated thyroid cancer: a quantitative dosimetric evaluation for remnant thyroid after surgery. J Nucl Med 1994; 35:1944-1950.
28. Maxon HR, Thomas SR, Hertzberg VS, Kereiakes JG, Chen IW, Sperling MI, et al. Relation between effective radiation dose and outcome of radioiodine therapy for thyroid cancer. N Engl J Med 1983; 309:937-941.
29. Creutzig H. High or low dose radioiodine ablation of thyroid remnants. Eur J Nucl Med 1987; 12:500-502.
30. Johansen K, Woodhouse NJY, Odugbesan O. Comparison of 1073 MBq and 3700 MBq iodine-131 in postoperative ablation of residual thyroid tissue in patient with differentiated thyroid cancer. J Nucl Med 1991; 32:252-254.
31. Lin JD, Kao PF, Chao TC. The effects of radioactive iodine in thyroid remnant ablation and treatment of well differentiated thyroid carcinoma. Br J Radiol 1998; 71:307-313.
32. Pacini F, Molinaro E, Castagna MG, Lippi F, Ceccarelli C, Agate L, et al. Ablation of thyroid residues with 30舁mCi (131)I: a comparison in thyroid cancer patients prepared with recombinant human TSH or thyroid hormone withdrawal. J Clin Endocrinol Metab 2002; 87:4063-4068.
33. Vermiglio F, Violi MA, Finocchiaro MD, Baldari S, Castagna MG, Moleti M, et al. Short-term effectiveness of low-dose radioiodine ablative treatment of thyroid remnants after thyroidectomy for differentiated thyroid cancer. Thyroid 1999; 9:387-391.
34. Bal CS, Kumar A, Pant GS. Radioiodine dose for remnant ablation in differentiated thyroid cancer: a randomized clinical trial in 509 patients. J Clin Endocrinol Metab 2004; 89:1666-1673.